T2 Biosystems, Inc. (TTOO)
NASDAQ: TTOO · IEX Real-Time Price · USD
5.07
-0.10 (-1.93%)
At close: Jul 19, 2024, 4:00 PM
5.11
+0.04 (0.79%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
T2 Biosystems Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for T2 Biosystems stock have an average target of 5.00, with a low estimate of 3.00 and a high estimate of 7.00. The average target predicts a decrease of -1.38% from the current stock price of 5.07.
Analyst Consensus: Hold
* Price targets were last updated on Apr 29, 2024.
Analyst Ratings
The average analyst rating for T2 Biosystems stock from 2 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Hold Maintains $12 → $3 | Hold | Maintains | $12 → $3 | -40.83% | Apr 29, 2024 |
Alliance Global Partners | Alliance Global Partners | Hold Maintains $12 → $7 | Hold | Maintains | $12 → $7 | +38.07% | Jul 13, 2023 |
Alliance Global Partners | Alliance Global Partners | Hold Maintains $220 → $150 | Hold | Maintains | $220 → $150 | +2,858.58% | Jan 24, 2023 |
Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades $1,250 → $250 | Strong Buy → Hold | Downgrades | $1,250 → $250 | +4,830.97% | Oct 14, 2022 |
Alliance Global Partners | Alliance Global Partners | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 7, 2022 |
Financial Forecast
Revenue This Year
10.71M
from 7.19M
Increased by 48.89%
Revenue Next Year
23.56M
from 10.71M
Increased by 120.00%
EPS This Year
-3.76
from -19.19
EPS Next Year
-1.43
from -3.76
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 11.0M | 24.3M | 35.4M | 48.5M | 64.1M |
Avg | 10.7M | 23.6M | 34.4M | 47.1M | 62.2M |
Low | 10.3M | 22.6M | 33.0M | 45.3M | 59.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 53.3% | 126.5% | 50.2% | 41.1% | 35.9% |
Avg | 48.9% | 120.0% | 45.9% | 37.1% | 32.0% |
Low | 43.1% | 111.4% | 40.2% | 31.7% | 26.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -3.87 | -1.47 | -0.87 | -0.59 | -0.39 |
Avg | -3.76 | -1.43 | -0.85 | -0.57 | -0.38 |
Low | -3.62 | -1.37 | -0.81 | -0.55 | -0.36 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.